New health systems directorate in EU's DG SANCO

11 May 2011

The European Commission Directorate in charge of health and consumers has been reorganized, with the main change being the addition of a new Health System and Products Directorate. The Commission has published its new organigram for DG SANCO, which will come into effect in the next few months.

The main change to the current structure is the creation of a new Directorate in DG SANCO to deal with health systems and products. The Directorate will be headed by Andrzej Jan Rys, a Polish national, who is currently Director Public Health and Risk Assessment Unit.

The Directorate will deal with health care systems, pharmaceuticals, tobacco control and risk assessment, as well as with strategy.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical